虚血性脳卒中:世界の治験レビュー(2017年下半期版)

調査会社GlobalData社が発行したリサーチレポート(データ管理コード:GDHC4676CTIDB)
◆英語タイトル:Ischemic Cerebral Stroke Global Clinical Trials Review, H2, 2017
◆発行会社/調査会社:GlobalData
◆商品コード:GDHC4676CTIDB
◆発行日:2017年10月31日
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後24時間以内)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[虚血性脳卒中:世界の治験レビュー(2017年下半期版)]についてメールでお問い合わせはこちら
当調査レポートでは、世界における虚血性脳卒中治療の臨床試験動向について調査・分析し、アジア/ヨーロッパ/アメリカ/中南米の主要国における治験件数、フェーズ別の治験件数、進捗状況別の治験件数、有望なスポンサー、有望な薬剤、治験関連の最新ニュース、主要企業分析、主要な治験プロファイル分析などの情報をご提供致します。
・虚血性脳卒中:主要地域別治験動向
・虚血性脳卒中:アジア市場
・虚血性脳卒中:ヨーロッパ市場
・虚血性脳卒中:アメリカ市場
・虚血性脳卒中:中南米市場
・虚血性脳卒中:中東・アフリカ市場
・虚血性脳卒中:段階(フェーズ)別治験件数
・虚血性脳卒中:進捗状況別の治験件数
・虚血性脳卒中:スポンサーの種類別治験件数
・虚血性脳卒中:有望なスポンサー
・虚血性脳卒中:有望な薬剤分析
・虚血性脳卒中:主要企業分析
*** レポート概要(サマリー)***

Ischemic Cerebral Stroke Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Ischemic Cerebral Stroke Global Clinical Trials Review, H2, 2017″ provides an overview of Ischemic Cerebral Stroke clinical trials scenario. This report provides top line data relating to the clinical trials on Ischemic Cerebral Stroke. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

*** レポート目次(コンテンツ)***

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Ischemic Cerebral Stroke to Cardiovascular Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Ischemic Cerebral Stroke to Cardiovascular Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Ischemic Cerebral Stroke Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profile Snapshots 29
Appendix 48
Abbreviations 48
Definitions 48
Research Methodology 49
Secondary Research 49
About GlobalData 50
Contact Us 50
Source 50

List of Tables
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials by Region, 2017* 6
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
Ischemic Cerebral Stroke Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 12
Proportion of Ischemic Cerebral Stroke to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 13
Ischemic Cerebral Stroke Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
Ischemic Cerebral Stroke Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
Proportion of Ischemic Cerebral Stroke to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 16
Ischemic Cerebral Stroke Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17
Ischemic Cerebral Stroke Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 18
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials by Phase, 2017* 19
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 20
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
Ischemic Cerebral Stroke Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 24
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28

List of Figures
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
Ischemic Cerebral Stroke Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 12
Proportion of Ischemic Cerebral Stroke to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 13
Ischemic Cerebral Stroke Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
Ischemic Cerebral Stroke Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
Proportion of Ischemic Cerebral Stroke to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 16
Ischemic Cerebral Stroke Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17
Ischemic Cerebral Stroke Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 18
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials by Phase (%), 2017* 19
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 20
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
Ischemic Cerebral Stroke Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 24
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28
GlobalData Methodology 49

*** 掲載企業 ***

Genervon Biopharmaceuticals LLC
Grifols SA
Giant Med-Pharma Services Inc
Fujian Jinshan Pharmaceutical Company Ltd
D-Pharm Ltd
Cidat SA de CV
Changchun Xiangtong Pharmaceutical Co Ltd
Celgene Corp
Celgene Cellular Therapeutics Inc
Athersys Inc

*** レポートのキーワード ***

虚血性脳卒中、治験、臨床試験、治療薬

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDHC4676CTIDB )"虚血性脳卒中:世界の治験レビュー(2017年下半期版)" (英文:Ischemic Cerebral Stroke Global Clinical Trials Review, H2, 2017)はGlobalData社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。